Failure of dabigatran following idarucizumab and omeprazole administration

被引：1
|
作者：
Mahawish, Karim M. [1 ]
Leung, Almond [1 ]
机构：
[1] MidCent DHB, Dept Internal Med, Palmerston North, New Zealand
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷 / 01期
关键词：
THROMBIN TIME;
D O I：
10.1111/imj.15159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 135
页数：2
相关论文
共 50 条
  • [21] Idarucizumab: A Review as a Reversal Agent for Dabigatran
    Yahiya Y. Syed
    American Journal of Cardiovascular Drugs, 2016, 16 : 297 - 304
  • [22] Evidence supporting idarucizumab for the reversal of dabigatran
    Pollack, Charles V., Jr.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (11): : 33 - 38
  • [23] Idarucizumab reverses haemorrhagic effects of dabigatran
    Reactions Weekly, 2018, 1721 (1) : 7 - 7
  • [24] Idarucizumab: A Review as a Reversal Agent for Dabigatran
    Syed, Yahiya Y.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (04) : 297 - 304
  • [25] Experience with idarucizumab as a reverse agent of dabigatran
    Bottaro, Federico J.
    Mercedes Margan, Maria
    Duboscq, Cristina
    Ceresetto, Jose M.
    MEDICINA-BUENOS AIRES, 2020, 80 (04) : 405 - 410
  • [26] Concerns about idarucizumab for dabigatran reversal
    Stoellberger, Claudia
    Pommer, Peter
    Schneider, Birke
    Finsterer, Josef
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (04) : 473 - 474
  • [27] Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
    Litwinowicz, Radoslaw
    Konstanty-Kalandyk, Janusz
    Goralczyk, Tadeusz
    Bartus, Krzysztof
    Mazur, Piotr
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (01) : 9 - 12
  • [28] Erroneous administration of the dabigatran antidote idarucizumab during surgery: case report and lessons learned
    Lavon, Ophir
    Musai, Yamit
    Shainer, Maayan
    Alroy-Preis, Sharon
    CLINICAL TOXICOLOGY, 2018, 56 (06) : 474 - 475
  • [29] Study: Idarucizumab is an effective Dabigatran Antidote
    不详
    ORTHOPADE, 2019, 48 (01): : 103 - 103
  • [30] Bleeding Antidote against Dabigatran: Idarucizumab
    Pollack, C. V., Jr.
    Reilly, P. A.
    Eikelboom, J.
    AKTUELLE NEUROLOGIE, 2015, 42 (09) : E118 - E118
12345